Radiopharm Theranostics Limited (RAD.AX)

AUD 0.02

(-8.7%)

Market Cap (In AUD)

45.63 Million

Revenue (In AUD)

299.22 Thousand

Net Income (In AUD)

-47.94 Million

Avg. Volume

4.39 Million

Currency
AUD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.021-0.1
PE
-
EPS
-
Beta Value
0.851
ISIN
AU0000181851
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Riccardo Canevari
Employee Count
-
Website
https://www.radiopharmtheranostics.com
Ipo Date
2021-11-24
Details
Radiopharm Theranostics Limited develops radiopharmaceutical products for diagnostic and therapeutic uses. The company was incorporated in 2021 and is based in Carlton, Australia.